Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
-
NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities
-
Genius Group increases Bitcoin Treasury to $35 million, ahead of schedule towards $120 million target.
-
BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week
-
Thumzup Media Corporation Offers $10,000 in Credits for Small Businesses to Support Recovery Efforts Following Los Angeles Wildfires
-
Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
-
Annexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” Jones
-
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
-
Netcapital Announces Exercise of Warrants
-
Horizon Aircraft Signs Letter of Intent with Discovery Air Chile Ltda., Expanding Global Presence of Cavorite X7 Hybrid eVTOLs
-
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
-
Portillo’s Adds Industry Veteran Jack Hartung to Board of Directors
-
4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path
-
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
-
Heritage Distilling Introduces Bitcoin Treasury Policy Statement
-
Compass Diversified Holdings Announces Amendment of its Credit Agreement
-
Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
-
ADDITIONAL RESULTS FROM THE LAPON CANYON PROJECT A NEVADA CANYON OWNED ROYALTY
-
Monster Beverage Announces Webcast Details For Investor Meeting/Business Update January 21, 2025
-
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
-
Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025
-
Veritex Holdings, Inc. Announces Dates of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
MIND CTI to Acquire Aurenz GmbH
-
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST) and Westwood Salient Enhanced Energy Income ETF (WEEI)
-
Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change
-
Michelin : Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
NEXTGEN DIGITAL ANNOUNCES $1.0 MILLION NON-BROKERED PRIVATE PLACEMENT FINANCING
-
Jeffs’ Brands Presents Estimated Year over Year Growth, Targets $20 million Revenue in 2025, Anticipates over 120% Revenue Growth since its IPO in 2022
-
Swipe-to-Earn Revolution: PAWS Goes Live on XT.COM
-
Enrolled Agents Are Taxpayers' Go-To Resource for Tax Season
-
Enrolled Agents Are Taxpayers' Go-To Resource for Tax Season
-
Notification of major shareholding
-
Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit
-
Constellation Brands Reports Third Quarter Fiscal 2025 Financial Results
-
CNB Financial Corporation and ESSA Bancorp, Inc. Announce Strategic Merger
-
Golconda Gold Ltd. Announces Appointment of Vikram Kapoor to Board and Equity Grants
-
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
-
Churchill Downs Incorporated 2024 Fourth Quarter and Full Year Financial Results Conference Call Invitation
-
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
-
ZenaTech’s ZenaDrone Multipurpose AI Drone Applies for FAA Part 137 Crop Sprayer Certification for Agricultural and Wildfire Industry Use
-
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
-
Ranchero Completes Debt Settlement Transaction
-
Prairie Operating Co. Completes Shelduck South Pad, Prepares for New Developments
-
Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
-
Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones
-
Alliance Witan PLC - Net Asset Value
-
Revolutionizing Psychology: Asian Conference on Applied Psychology 2025 Unveils VR Networking and Global Collaboration
-
Y-mAbs Provides Strategic Business Update and 2025 Priorities
-
HBT Financial, Inc. to Announce Fourth Quarter 2024 Financial Results on January 22, 2025
-
G2 Names INE 2025 Networking and Cybersecurity Training Leader
